Greenwich LifeSciences
GLSI
34 hedge funds and large institutions have $8.74M invested in Greenwich LifeSciences in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 13 closing their positions.
10% more capital inflows, than outflows
Capital inflows: $5.48M | Capital outflows: $5M
8% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 13
0.75% more ownership
Funds ownership: 7.19% → 7.94% (+0.75%)
0% more funds holding
Funds holding: 34 → 34 (0)
30% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$1.21M |
| 2 |
Millennium Management
New York
|
+$1.03M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$789K |
| 4 |
Morgan Stanley
New York
|
+$590K |
| 5 |
Occudo Quantitative Strategies
Fort Lauderdale,
Florida
|
+$269K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$2.12M |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$688K |
| 3 |
State Street
Boston,
Massachusetts
|
-$613K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$329K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$240K |
GLSI Hedge Fund Activity: Q2 2022 in Review
34 of the 5,963 institutional investors tracked by Wall St. Rank reported a position in Greenwich LifeSciences (GLSI) for Q2 2022, worth a combined $8.74M — down 52% from $18.3M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new GLSI positions and 13 closed out — a net gain of 1 holder — while 7 added to existing stakes and 10 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $1.21M. The largest seller was BlackRock, cutting an estimated $2.12M.
- 34 institutional investors held Greenwich LifeSciences (GLSI) as of Q2 2022, unchanged from Q1 2022.
- Funds reported $8.74M of Greenwich LifeSciences stock for Q2 2022, down 52% quarter-over-quarter.
- 14 funds opened new Greenwich LifeSciences positions in Q2 2022 and 13 closed out, a net change of +1 holder.
- The largest Greenwich LifeSciences buyer in Q2 2022 was Renaissance Technologies, an estimated $1.21M added.
- The largest Greenwich LifeSciences seller in Q2 2022 was BlackRock, an estimated $2.12M sold.
Based on aggregated 13F filings for Q2 2022.